🌸
C A N C E R
Cure Cancer
Cure with Wheatgrass
Cancer... / Dr. Circus
Cancer Risk / At Home
Cancer & Vitamin C
Dr. Leonard Caldwel
Ginger & Cancer
Hot Dog = Cancer
Potato Chips
Thyme Oil / Chamomile
7 Top Cancer Foods
http://www.kindness2.com/truth-about-cancer.html
🌸
C A N C E R
Cure Cancer
Cure with Wheatgrass
Cancer... / Dr. Circus
Cancer Risk / At Home
Cancer & Vitamin C
Dr. Leonard Caldwel
Ginger & Cancer
Hot Dog = Cancer
Potato Chips
Thyme Oil / Chamomile
7 Top Cancer Foods
http://www.kindness2.com/truth-about-cancer.html
🌸
🌸
[Start at the 5:30 minute mark, in order to bypass introductory comments
and get right to the subject.]
🌸
[Start at the 5:30 minute mark, in order to bypass introductory comments
and get right to the subject.]
🌸
This article may be reprinted free of charge provided
1) that there is clear attribution to the Orthomolecular Medicine News Service, and
2) that both the OMNS free subscription link
http://orthomolecular.org/subscribe.html and also the OMNS archive link http://orthomolecular.org/resources/omns/index.shtml are included.
Click here to see a web copy of this news release
Orthomolecular Medicine News Service
The Metabolic Roots of Cancerby Ron Hunninghake, M.D.(OMNS, April 6, 2016) My experience working with cancer patients has taught me three keys to understanding their needs:
Dr. Hugh D. Riordan, my mentor, recognized a huge gap in the cancer care system. Trained as a psychiatrist, he acknowledged cancer patients for their fears, their questions, their pain, their family stress, their treatment side effects, their fatigue, their anxieties and their hopes for a real cure.
As a realist, he knew that "silver bullet" "single cause" "fix the bad gene" ideas from the parsimonious first age of scientific medicine were generally not working. He found a better way.
In The Metabolic Roots of Cancer, recorded at the 4th Riordan Intravenous Vitamin C and Cancer Symposium in Wichita, Kansas, I present a systems theory perspective on caring for the cancer patient.
37 minutes into the program, there is included a brief summary of what intravenous vitamin C (IVC) can do to help the cancer patient. But IVC is not enough.
Shooting a silver bullet is probably not the whole answer. Rather, addressing taproots and root causes may be a big step in the right direction.
The link for free online viewing is https://www.youtube.com/watch?v=9iolNb7NadU
View it Above.
[Start at the 5:30 minute mark, in order to bypass introductory comments and get right to the subject.]
(Dr. Ron Hunninghake has worked as an orthomolecular physician for 28 years. He is Chief Medical Officer at the Riordan Clinic, and has been inducted into the Orthomolecular Medicine Hall of Fame.)
More Videos on Intravenous Vitamin C (IVC) and Cancer:
Explaining the Riordan IVC Protocol
https://www.youtube.com/watch?v=04cOSwZ43II
For a free download of a printable copy of the complete Riordan IVC protocol:
http://riordanclinic.org/wp-content/uploads/2014/11/Riordan_IVC_Protocol.pdf
Also at http://www.doctoryourself.com/RiordanIVC.pdf
Nutritional Medicine is Orthomolecular Medicine
Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org
Find a DoctorTo locate an orthomolecular physician near you:
http://orthomolecular.org/resources/omns/v06n09.shtml
The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.
Editorial Review Board:Ian Brighthope, M.D. (Australia)
Ralph K. Campbell, M.D. (USA)
Carolyn Dean, M.D., N.D. (USA)
Damien Downing, M.D. (United Kingdom)
Michael Ellis, M.D. (Australia)
Martin P. Gallagher, M.D., D.C. (USA)
Michael Gonzalez, D.Sc., Ph.D. (Puerto Rico)
William B. Grant, Ph.D. (USA)
Michael Janson, M.D. (USA)
Robert E. Jenkins, D.C. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Peter H. Lauda, M.D. (Austria)
Thomas Levy, M.D., J.D. (USA)
Stuart Lindsey, Pharm.D. (USA)
Joseph Mercola, D.O. (USA)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
Erik Paterson, M.D. (Canada)
W. Todd Penberthy, Ph.D. (USA)
Jeffrey A. Ruterbusch, D.O. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
Jagan Nathan Vamanan, M.D. (India)
Ken Walker, M.D. (Canada)
Atsuo Yanagisawa, M.D., Ph.D. (Japan)
Robert G. Smith, Ph.D. (USA), Assistant Editor
Helen Saul Case, M.S. (USA), Assistant Editor
Michael S. Stewart, B.Sc.C.S. (USA), Technology Editor
Andrew W. Saul, Ph.D. (USA), Editor and contact person.
Email: drsaul@doctoryourself.com
This is a comments-only address; OMNS is unable to respond to individual reader emails. However, readers are encouraged to write in with their viewpoints. Reader comments become the property of OMNS and may or may not be used for publication.
Click here to see a web copy of this news release: http://orthomolecular.activehosted.com/p_v.php?l=1&c=34&m=36&s=6607ecf4d5b295707a9ed5a11fa9d5a1
This article may be reprinted free of charge provided 1) that there is clear attribution to the Orthomolecular Medicine News Service, and 2) that both the OMNS free subscription link
http://orthomolecular.org/subscribe.html and also the OMNS archive link http://orthomolecular.org/resources/omns/index.shtml are included.
Riordan Clinic | Orthomolecular.org
3100 N Hillside Ave
Wichita, Kansas 67219
United States
Forward to a Friend
1) that there is clear attribution to the Orthomolecular Medicine News Service, and
2) that both the OMNS free subscription link
http://orthomolecular.org/subscribe.html and also the OMNS archive link http://orthomolecular.org/resources/omns/index.shtml are included.
Click here to see a web copy of this news release
Orthomolecular Medicine News Service
The Metabolic Roots of Cancerby Ron Hunninghake, M.D.(OMNS, April 6, 2016) My experience working with cancer patients has taught me three keys to understanding their needs:
- Cancer statistics are faceless; the illness is real.
- Doctors mostly approach the disease through statistics; real patients need real caring.
- Real caring is personal, and incorporates a multifaceted approach that addresses all of the metabolic roots of cancer, without sacrificing conventional cancer care.
Dr. Hugh D. Riordan, my mentor, recognized a huge gap in the cancer care system. Trained as a psychiatrist, he acknowledged cancer patients for their fears, their questions, their pain, their family stress, their treatment side effects, their fatigue, their anxieties and their hopes for a real cure.
As a realist, he knew that "silver bullet" "single cause" "fix the bad gene" ideas from the parsimonious first age of scientific medicine were generally not working. He found a better way.
In The Metabolic Roots of Cancer, recorded at the 4th Riordan Intravenous Vitamin C and Cancer Symposium in Wichita, Kansas, I present a systems theory perspective on caring for the cancer patient.
37 minutes into the program, there is included a brief summary of what intravenous vitamin C (IVC) can do to help the cancer patient. But IVC is not enough.
Shooting a silver bullet is probably not the whole answer. Rather, addressing taproots and root causes may be a big step in the right direction.
The link for free online viewing is https://www.youtube.com/watch?v=9iolNb7NadU
View it Above.
[Start at the 5:30 minute mark, in order to bypass introductory comments and get right to the subject.]
(Dr. Ron Hunninghake has worked as an orthomolecular physician for 28 years. He is Chief Medical Officer at the Riordan Clinic, and has been inducted into the Orthomolecular Medicine Hall of Fame.)
More Videos on Intravenous Vitamin C (IVC) and Cancer:
Explaining the Riordan IVC Protocol
https://www.youtube.com/watch?v=04cOSwZ43II
For a free download of a printable copy of the complete Riordan IVC protocol:
http://riordanclinic.org/wp-content/uploads/2014/11/Riordan_IVC_Protocol.pdf
Also at http://www.doctoryourself.com/RiordanIVC.pdf
Nutritional Medicine is Orthomolecular Medicine
Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org
Find a DoctorTo locate an orthomolecular physician near you:
http://orthomolecular.org/resources/omns/v06n09.shtml
The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.
Editorial Review Board:Ian Brighthope, M.D. (Australia)
Ralph K. Campbell, M.D. (USA)
Carolyn Dean, M.D., N.D. (USA)
Damien Downing, M.D. (United Kingdom)
Michael Ellis, M.D. (Australia)
Martin P. Gallagher, M.D., D.C. (USA)
Michael Gonzalez, D.Sc., Ph.D. (Puerto Rico)
William B. Grant, Ph.D. (USA)
Michael Janson, M.D. (USA)
Robert E. Jenkins, D.C. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Peter H. Lauda, M.D. (Austria)
Thomas Levy, M.D., J.D. (USA)
Stuart Lindsey, Pharm.D. (USA)
Joseph Mercola, D.O. (USA)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
Erik Paterson, M.D. (Canada)
W. Todd Penberthy, Ph.D. (USA)
Jeffrey A. Ruterbusch, D.O. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
Jagan Nathan Vamanan, M.D. (India)
Ken Walker, M.D. (Canada)
Atsuo Yanagisawa, M.D., Ph.D. (Japan)
Robert G. Smith, Ph.D. (USA), Assistant Editor
Helen Saul Case, M.S. (USA), Assistant Editor
Michael S. Stewart, B.Sc.C.S. (USA), Technology Editor
Andrew W. Saul, Ph.D. (USA), Editor and contact person.
Email: drsaul@doctoryourself.com
This is a comments-only address; OMNS is unable to respond to individual reader emails. However, readers are encouraged to write in with their viewpoints. Reader comments become the property of OMNS and may or may not be used for publication.
Click here to see a web copy of this news release: http://orthomolecular.activehosted.com/p_v.php?l=1&c=34&m=36&s=6607ecf4d5b295707a9ed5a11fa9d5a1
This article may be reprinted free of charge provided 1) that there is clear attribution to the Orthomolecular Medicine News Service, and 2) that both the OMNS free subscription link
http://orthomolecular.org/subscribe.html and also the OMNS archive link http://orthomolecular.org/resources/omns/index.shtml are included.
Riordan Clinic | Orthomolecular.org
3100 N Hillside Ave
Wichita, Kansas 67219
United States
Forward to a Friend
🌸
🌸
High Dose IV Vitamin C Therapy
An Oasis of Healing Alternative Cancer Healing Center
(480) 834 - 5414 / Owner / Dr. Thomas Lodi / Phoenix, AZ
“ It is not often difficult to get rid of cancer. The problem is keeping it gone”
http://www.anoasisofhealing.com/our-program/target-eliminate- cancer/intravenous-vitamin-c/
🌸
High Dose IV Vitamin C Therapy
An Oasis of Healing Alternative Cancer Healing Center
(480) 834 - 5414 / Owner / Dr. Thomas Lodi / Phoenix, AZ
“ It is not often difficult to get rid of cancer. The problem is keeping it gone”
http://www.anoasisofhealing.com/our-program/target-eliminate- cancer/intravenous-vitamin-c/
🌸
Cancer cells, unlike healthy human cells are both defective and primitive. Not only are they unable to use oxygen to metabolize glucose into energy, they are either lacking or completely deficient in many enzymes that normal cells have in abundance. One such enzyme is “catalase,” which transforms oxygen and water into hydrogen peroxide, and vice versa.
High doses of ascorbic acid (Vitamin C) result in the production of peroxides in and around cells. Healthy cells use the hydrogen peroxide for certain metabolic needs and the excess is converted into water and oxygen (good stuff). Since cancer cells have very little catalase, they are unable to convert the hydrogen peroxide into water and oxygen and consequently are oxidized and killed. So vitamin C is “good” for healthy cells and “bad” for cancer cells.
The National Institute of Health (NIH), the National Cancer Institute (NCI) and the Food and Drug Administration (FDA) have finally confirmed the research findings that Linus Pauling, PhD, Hugh Riordan, MD and many other scientists and physicians over the past few decades have conducted regarding the therapeutic utility of treating cancer with vitamin C.
The NI study confirms in vitro, the hypotheses described by Riordan et al in “Intravenous Ascorbate as a Chemotherapeutic and Biologic Response Modifying Agent”: Tumor cells are more susceptible to the effects of high- dose, ascorbate-induced peroxidation products because of a relative catalase deficiency. Concentrations of ascorbate high enough to kill tumor cells can be achieved in humans.
High doses of ascorbic acid (Vitamin C) result in the production of peroxides in and around cells. Healthy cells use the hydrogen peroxide for certain metabolic needs and the excess is converted into water and oxygen (good stuff). Since cancer cells have very little catalase, they are unable to convert the hydrogen peroxide into water and oxygen and consequently are oxidized and killed. So vitamin C is “good” for healthy cells and “bad” for cancer cells.
The National Institute of Health (NIH), the National Cancer Institute (NCI) and the Food and Drug Administration (FDA) have finally confirmed the research findings that Linus Pauling, PhD, Hugh Riordan, MD and many other scientists and physicians over the past few decades have conducted regarding the therapeutic utility of treating cancer with vitamin C.
The NI study confirms in vitro, the hypotheses described by Riordan et al in “Intravenous Ascorbate as a Chemotherapeutic and Biologic Response Modifying Agent”: Tumor cells are more susceptible to the effects of high- dose, ascorbate-induced peroxidation products because of a relative catalase deficiency. Concentrations of ascorbate high enough to kill tumor cells can be achieved in humans.
Listed below are several, peer reviewed references regarding
vitamin C as it pertains to the treatment of cancer.
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues
Qi Chen *, Michael Graham Espey, Murali C. Krishna, James B. Mitchell, Christopher P. Corpe *, Garry R. Buettner, Emily Shacter, and Mark Levine * Reference Link
*Molecular and Clinical Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; Radiation Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Free Radical and Radiation Biology Program, University of Iowa, Iowa City, IA 52242-1101; and Laboratory of Biochemistry, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892 PNAS | September 20, 2005 | vol. 102 | no. 38 | 13604-13609
Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later
By Michael J. González, Jorge R. Miranda-Massari, Edna M. Mora, Angelik Guzmán, Neil H. Riordan, Hugh D. Riordan, Joseph J. Casciari, James A. Jackson, and Angel Romá-Franco, from Integrative Cancer Therapies 4(1); 2005 pp.32-44
Intravenous Ascorbic Acid: Protocol for its Application and Use
By Hugh D. Riordan, Ronald E. Hunninghake, Neil H. Riordan, James A. Jackson, Xiao LongMeng, Paul Taylor, etal, from Puerto Rico Health Sciences Journal (2003) 22:3, 287-290
The Effect of Alternating Magnetic Field Exposure and Vitamin C on Cancer Cells
By N. Mikirova, J.A. Jackson, J.P. Casciari and H.D. Riordan, from Journal of Orthomolecular Medicine (2001) 3, 177-182
Cytotoxicity of Ascorbate, Lipoic Acid, and Other Antioxidants In Hollow Fibre In Vitro Tumours
By J.P. Casciari, N.H. Riordan, T.L. Schmidt, XL Meng, J.A. Jackson and H.D. Riordan, from British Journal of Cancer (2001) 84:11, 1544-1550
Clinical and Experimental Experiences with Intravenous Vitamin C
By N.H. Riordan, H.D. Riordan, J.A. Jackson and J.P. Casciari, from Journal of Orthomolecular Medicine (2000) 15:4, 201-213
Different Fatty Acid Composition Between Normal and Malignant Cell Lines
By X.L. Meng, N.H. Riordan, H.D. Riordan, J.A. Jackson, et al, from BioMedicina, (1999) 2:4, 5-7
Rethinking Vitamin C and Cancer: An Update on Nutritional Oncology
By M.J. Gonzalez, E. Mora, N.H. Riordan, H.D. Riordan and P. Mojica, from Cancer Prevention International (1998) 3, 215-224
Intravenous Ascorbate as a Chemotherapeutic and Biologic Response Modifying Agent
Bio-Communications Research Institute (1997)
Intravenous Vitamin C in a Terminal Cancer Patient
By N.H. Riordan, J.A. Jackson and H.D. Riordan, from Journal of Orthomolecular Medicine (1996) 11, 80-82
High-Dose Intravenous Vitamin C and Long-Time Survival of a Patient with Cancer of Head of the Pancreas
By J.A. Jackson, H.D. Riordan, R.E. Hunninghake and N.H. Riordan, from Journal of Orthomolecular Medicine (1995) 10, 87-88
Intravenous Ascorbate as a Tumor Cytotoxic Chemotherapeutic Agent
By N.H. Riordan, H.D. Riordan, X. Meng, Y. Li and J.A. Jackson, from Medical Hypotheses (1995) 44, 207-213
Case Study: High-Dose Intravenous Vitamin C in the Treatment of a Patient withAdenocarcinoma of the Kidney
By H.D. Riordan, J.A. Jackson and Mavis Schultz, from Journal of Orthomolecular Medicine (1990) 5:1, 5-7
Cited From: http://www.anoasisofhealing.com/our-program/target-eliminate-cancer/intravenous-vitamin-c/#ixzz456sgrFvJ
vitamin C as it pertains to the treatment of cancer.
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues
Qi Chen *, Michael Graham Espey, Murali C. Krishna, James B. Mitchell, Christopher P. Corpe *, Garry R. Buettner, Emily Shacter, and Mark Levine * Reference Link
*Molecular and Clinical Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; Radiation Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Free Radical and Radiation Biology Program, University of Iowa, Iowa City, IA 52242-1101; and Laboratory of Biochemistry, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892 PNAS | September 20, 2005 | vol. 102 | no. 38 | 13604-13609
Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later
By Michael J. González, Jorge R. Miranda-Massari, Edna M. Mora, Angelik Guzmán, Neil H. Riordan, Hugh D. Riordan, Joseph J. Casciari, James A. Jackson, and Angel Romá-Franco, from Integrative Cancer Therapies 4(1); 2005 pp.32-44
Intravenous Ascorbic Acid: Protocol for its Application and Use
By Hugh D. Riordan, Ronald E. Hunninghake, Neil H. Riordan, James A. Jackson, Xiao LongMeng, Paul Taylor, etal, from Puerto Rico Health Sciences Journal (2003) 22:3, 287-290
The Effect of Alternating Magnetic Field Exposure and Vitamin C on Cancer Cells
By N. Mikirova, J.A. Jackson, J.P. Casciari and H.D. Riordan, from Journal of Orthomolecular Medicine (2001) 3, 177-182
Cytotoxicity of Ascorbate, Lipoic Acid, and Other Antioxidants In Hollow Fibre In Vitro Tumours
By J.P. Casciari, N.H. Riordan, T.L. Schmidt, XL Meng, J.A. Jackson and H.D. Riordan, from British Journal of Cancer (2001) 84:11, 1544-1550
Clinical and Experimental Experiences with Intravenous Vitamin C
By N.H. Riordan, H.D. Riordan, J.A. Jackson and J.P. Casciari, from Journal of Orthomolecular Medicine (2000) 15:4, 201-213
Different Fatty Acid Composition Between Normal and Malignant Cell Lines
By X.L. Meng, N.H. Riordan, H.D. Riordan, J.A. Jackson, et al, from BioMedicina, (1999) 2:4, 5-7
Rethinking Vitamin C and Cancer: An Update on Nutritional Oncology
By M.J. Gonzalez, E. Mora, N.H. Riordan, H.D. Riordan and P. Mojica, from Cancer Prevention International (1998) 3, 215-224
Intravenous Ascorbate as a Chemotherapeutic and Biologic Response Modifying Agent
Bio-Communications Research Institute (1997)
Intravenous Vitamin C in a Terminal Cancer Patient
By N.H. Riordan, J.A. Jackson and H.D. Riordan, from Journal of Orthomolecular Medicine (1996) 11, 80-82
High-Dose Intravenous Vitamin C and Long-Time Survival of a Patient with Cancer of Head of the Pancreas
By J.A. Jackson, H.D. Riordan, R.E. Hunninghake and N.H. Riordan, from Journal of Orthomolecular Medicine (1995) 10, 87-88
Intravenous Ascorbate as a Tumor Cytotoxic Chemotherapeutic Agent
By N.H. Riordan, H.D. Riordan, X. Meng, Y. Li and J.A. Jackson, from Medical Hypotheses (1995) 44, 207-213
Case Study: High-Dose Intravenous Vitamin C in the Treatment of a Patient withAdenocarcinoma of the Kidney
By H.D. Riordan, J.A. Jackson and Mavis Schultz, from Journal of Orthomolecular Medicine (1990) 5:1, 5-7
Cited From: http://www.anoasisofhealing.com/our-program/target-eliminate-cancer/intravenous-vitamin-c/#ixzz456sgrFvJ
Cancer Treatment with IV vitamin C Recent clinical success
by: Ethan Evers
(NaturalNews) The use of IV (intravenous) vitamin C to treat cancer is growing in popularity around the world as positive research continues to accumulate and build a strong case for its effectiveness. The latest cohort study out of Germany is one more example, showing that IV vitamin C markedly improves the quality of life for breast cancer patients. Such positive results are likely the reason why many thousands of patients worldwide elect to be treated with this therapy every year.
IV Vitamin C for Cancer Treatment: Current Status
It is now well established that by injecting vitamin C we can safely reach concentrations at which ascorbate generates hydrogen peroxide (H2O2) in tissues, and it is the H2O2 that selectively kills cancer cells through oxidative stress. Laboratory studies have confirmed that high-dose vitamin C is cytotoxic to a wide variety of cancer cell lines, and that it also boosts the anti- cancer activity of several common chemotherapy drugs.
In animal models (rats), IV vitamin C has been shown to significantly decrease growth rates of liver, ovarian, pancreatic, and glioblastoma tumors with dosages easily achievable in humans. The science behind IV vitamin C as a cancer therapy is now so advanced that there are six clinical trials testing it (alone or with chemo drugs) in human patients against lymphoma and cancers of the colon, breast, uterus, cervix, prostate, pancreas and others.
IV Vitamin C Helps Cancer Patients: Clinical Evidence
Clinical trials have not yet shown IV vitamin C to shrink tumours, but that's no reason for an oncologist to reject this therapy. Improving quality of life is also an important goal of cancer treatment, and clinical experience shows IV vitamin C does exactly that.
A prospective study from Korea (2007) showed that this therapy significantly improved quality of life for terminal cancer patients, bringing the global health/quality of life score from 36 to 55 and yielding improvements in physical, emotional, and cognitive functions. Disease symptom severity also decreased across the board, with patients showing significantly less fatigue, nausea/vomiting, pain, and appetite loss.
These results were echoed in a study just completed in late 2011 in Germany, which compared breast cancer patients receiving IV vitamin C and standard therapy together, versus standard therapy alone. Those receiving IV vitamin C experienced a marked reduction (nearly 50%) in unpleasant symptoms and chemo/radiotherapy side effects such as loss of appetite, fatigue, depression, sleep disorders, dizziness and haemorrhagic diathesis.
The IV Vitamin C is More Widespread Than You Think
Experiences such as those above are bringing more patients to try IV vitamin C - as are high profile patients. For example, the celebrated New Zealand physicist Sir Paul Callaghan elected to treat his colon cancer with IV vitamin C, and his CEA level (a colon cancer marker) started to decrease after only six infusions.
This therapy is already widespread in New Zealand: 30 clinics provide it, administering about 10,000 vitamin C injections annually. In the US, a recent survey showed that over 8800 patients were treated with IV vitamin C in 2008, using a total of 355,000 dosage vials. But that was just for the health care practitioners taking part in the survey.
For the same year, manufacturers reported sales of 855,000 vials of vitamin C. This implies that as many as 21,000 patients received IV vitamin C therapy in 2008. Ongoing clinical trials using IV vitamin C to treat cancer won't complete until 2013 to 2014.
But until then, clinical evidence already shows that this therapy can - at the very least - significantly improve cancer patients' quality of life. Oncologists should therefore strongly consider adding this therapy to their standard clinical practice. Many thousands of patients worldwide elect to be treated with this therapy every year.
http://www.naturalnews.com/034663_IV_vitamin_c_cancer_treatment.html
by: Ethan Evers
(NaturalNews) The use of IV (intravenous) vitamin C to treat cancer is growing in popularity around the world as positive research continues to accumulate and build a strong case for its effectiveness. The latest cohort study out of Germany is one more example, showing that IV vitamin C markedly improves the quality of life for breast cancer patients. Such positive results are likely the reason why many thousands of patients worldwide elect to be treated with this therapy every year.
IV Vitamin C for Cancer Treatment: Current Status
It is now well established that by injecting vitamin C we can safely reach concentrations at which ascorbate generates hydrogen peroxide (H2O2) in tissues, and it is the H2O2 that selectively kills cancer cells through oxidative stress. Laboratory studies have confirmed that high-dose vitamin C is cytotoxic to a wide variety of cancer cell lines, and that it also boosts the anti- cancer activity of several common chemotherapy drugs.
In animal models (rats), IV vitamin C has been shown to significantly decrease growth rates of liver, ovarian, pancreatic, and glioblastoma tumors with dosages easily achievable in humans. The science behind IV vitamin C as a cancer therapy is now so advanced that there are six clinical trials testing it (alone or with chemo drugs) in human patients against lymphoma and cancers of the colon, breast, uterus, cervix, prostate, pancreas and others.
IV Vitamin C Helps Cancer Patients: Clinical Evidence
Clinical trials have not yet shown IV vitamin C to shrink tumours, but that's no reason for an oncologist to reject this therapy. Improving quality of life is also an important goal of cancer treatment, and clinical experience shows IV vitamin C does exactly that.
A prospective study from Korea (2007) showed that this therapy significantly improved quality of life for terminal cancer patients, bringing the global health/quality of life score from 36 to 55 and yielding improvements in physical, emotional, and cognitive functions. Disease symptom severity also decreased across the board, with patients showing significantly less fatigue, nausea/vomiting, pain, and appetite loss.
These results were echoed in a study just completed in late 2011 in Germany, which compared breast cancer patients receiving IV vitamin C and standard therapy together, versus standard therapy alone. Those receiving IV vitamin C experienced a marked reduction (nearly 50%) in unpleasant symptoms and chemo/radiotherapy side effects such as loss of appetite, fatigue, depression, sleep disorders, dizziness and haemorrhagic diathesis.
The IV Vitamin C is More Widespread Than You Think
Experiences such as those above are bringing more patients to try IV vitamin C - as are high profile patients. For example, the celebrated New Zealand physicist Sir Paul Callaghan elected to treat his colon cancer with IV vitamin C, and his CEA level (a colon cancer marker) started to decrease after only six infusions.
This therapy is already widespread in New Zealand: 30 clinics provide it, administering about 10,000 vitamin C injections annually. In the US, a recent survey showed that over 8800 patients were treated with IV vitamin C in 2008, using a total of 355,000 dosage vials. But that was just for the health care practitioners taking part in the survey.
For the same year, manufacturers reported sales of 855,000 vials of vitamin C. This implies that as many as 21,000 patients received IV vitamin C therapy in 2008. Ongoing clinical trials using IV vitamin C to treat cancer won't complete until 2013 to 2014.
But until then, clinical evidence already shows that this therapy can - at the very least - significantly improve cancer patients' quality of life. Oncologists should therefore strongly consider adding this therapy to their standard clinical practice. Many thousands of patients worldwide elect to be treated with this therapy every year.
http://www.naturalnews.com/034663_IV_vitamin_c_cancer_treatment.html
🌸
🌸
Papaya is Tasty Way to Fight Cancer and Poor Digestion
http://www.naturalnews.com/026372_cancer_papaya_enzymes.html
by: Barbara L. Minton
Tags: papaya, health news, Natural News
(NewsTarget) Sweet and succulent with a satiny consistency, papaya was referred to as the "fruit of the angels" by Christopher Columbus. Slice open a papaya and see hundreds of shiny black seeds that all need to get their start in life from the nutrition found in the fruit. This implies that fruit must be power-packed. Scientists have documented this common sense observation by finding that papaya promotes digestive health and intestinal cleansing, fights inflammation, and supports the immune system. It protects lung and joint health, revitalizes the body, and boosts energy levels. Papaya is a potent cancer fighter that is highly effective against hormone related cancers as well as other cancers. New research shows papaya can stop the growth of breast cancer cells, halt metastasis, and normalize the cell cycle.
Papaya was the only studied food found to halt breast cancer
Scientists studied 14 plant foods commonly consumed in Mexico to determine their ability to halt breast cancer cell growth. These included avocado, black sapote, fuava, mango, prickly pear cactus (nopal), pineapple, grapes, tomato, and papaya. They also evaluated beta-carotene, total plant phenolics, and gallic acid contents and antioxidant capacity. They found that only papaya had a significant effect on stopping breast cancer cell growth. (International Journal of Food Science and Nutrition, May)
Papaya is a store-house of cancer fighting lycopene
The intense orangey-pink color of papaya means it is chock full of cancer fighting carotenoids. Not only beta carotene, but lycopene is found in abundance. The construction of lycopene makes it highly reactive toward oxygen and free radicals. Scientists at the University of Illinois think this anti-oxidant activity contributes to its effectiveness as a cancer fighting agent. Epidemiological studies have indicated an inverse relationship between lycopene intake and prostate cancer risk. They showed that oral lycopene is highly bioavailable, accumulates in prostate tissue, and is localized in the nucleus of prostate epithelial cells.
In addition to antioxidant activity, other experiments have indicated that lycopene induces cancer cell death, anti-metastatic activity, and the up-regulation of protective enzymes. Phase I and II studies have established the safety of lycopene supplementation. (Cancer Letter, October 8, 2008)
Prostate cancer was the subject of a study in Australia that looked at 130 prostate cancer patients and 274 hospitalized controls. The scientists found that men who consumed the most lycopene-rich fruits and vegetables such as papaya were 82% less likely to have prostate cancer. In this study, green tea also exerted a powerful anti-cancer effect. When lycopene-rich foods were consumed with green tea, the combination was even more effective, an outcome the researchers credited to their synergy. (Asia Pacific Journal of Clinical Nutrition, 2007)
Isothiocyanates found in papaya restore the cell cycle to eliminate cancer
Organo-sulfur compounds called isothiocyanates are found in papaya. In animal experiments, isothiocyanates protected against cancers of the breast, lung, colon pancreas, and prostate, as well as leukemia, and they have the potential to prevent cancer in humans. Isothiocyanates have shown themselves capable of inhibiting both the formation and development of cancer cells through multiple pathways and mechanisms. (International Journal of Oncology), October, 2008)
Researchers in Japan clarified the mechanisms of action in a type of isothiocyanate found in papaya known as BITC, that underlies the relationship between cell cycle regulation and appropriate cell death. When cancerous cells die on schedule, they are no longer a problem. The researchers established that BITC exerted cancer cell killing effects that were greater in the proliferating cells than in the quiescent cells. Cancer cells that are proliferating are much more dangerous than cancer cells that are in a state of dormancy. (Forum of Nutrition, 2009)
Enzymes from papaya digest proteins including those that protect tumors
The fruit and other parts of the papaya tree, also known as the paw paw tree, contain papain and chymopapain, powerful proteolytic enzymes that facilitate chemical reactions in the body. They promote digestion by helping to break down proteins from food into amino acids that can be recombined to produce protein useable by humans. Proteolytic enzymes protect the body from inflammation and help heal burns. They do a good job of digesting unwanted scar tissue both on the skin and under its surface.
Research has shown that the physical and mental health of people is highly dependent on their ability to produce proteins they can use effectively. However, as people age, they produce less of the enzymes needed to effectively digest proteins from food and free needed amino acids. They are left with excessive amounts of undigested protein which can lead to overgrowth of unwanted bacteria in the intestinal tract, and a lack of available amino acids.
Eating papaya after a meal promotes digestion, and helps prevent bloating, gas production, and indigestion. It is quite helpful after antibiotic use to replenish friendly intestinal bacteria that were the casualties in the war against the unwanted bacteria. When the intestinal tract is well populated with friendly bacteria, the immune system is strengthened, and can better protect against flu and cancer.
Being a proteolytic enzyme, papain is able to destroy intestinal parasites, which are composed mostly of protein. To rid the body of intestinal parasites, half a cup of papaya juice can be alternated each hour for twelve consecutive hours with the same amount of cucumber or green bean juice.
Papaya contains fibrin, another useful compound not readily found in the plant kingdom. Fibrin reduces the risk of blood clots and improves the quality of blood cells, optimizing the ability of blood to flow through the circulatory system. Fibrin is also important in preventing stokes. Proteolytic enzymes containing fibrin are a good idea for long plane rides to minimize the potential of blood clots in the legs. People who sit at a desk all day might want to use proteolytic enzymes too.
Proteolytic enzymes are able to digest and destroy the defense shields of viruses, tumors, allergens, yeasts, and various forms of fungus. Once the shield is destroyed, tumors and invading organisms are extremely vulnerable and easily taken care of by the immune system.
Undigested proteins can penetrate the gut and wind up in the bloodstream where they are treated by the immune system as invaders. If too many undigested proteins are floating around, the immune system becomes overburdened and unable to attend to the other tasks it was meant to do. Proteolytic enzymes can digest these rogue proteins, freeing up the immune system.
Papaya offers luscious taste and super nutrition
Papayas are native to Central America. They were disbursed by Spanish and Portuguese explorers who journeyed to India, the Philippines and Africa. Today, most commercially available papaya is produced in the U.S., Mexico and Puerto Rico.
Papaya adds the sunlight of the tropics to summer drinks while flooding the body with high class antioxidants such as carotenes, vitamin C and flavonoids. It is rich in several B vitamins including folate and pantothenic acid. It contains ample amounts of potassium, and plenty of magnesium, the mineral most deficient in Americans. It is also a good source of fiber.
Try getting some of these nutrients with a Papaya-Banana Smoothie
Ingredients
1 cup of whatever kind of milk pleases you
1/4 cup Greek style yogurt
1 tsp pure vanilla extract
1/2 ripe papaya, peeled, seeded and chopped
1 banana, peeled and sliced
1 cup ice cubes
Directions
Combine all ingredients in a blender and blend until smooth. Pour into a large glass and garnish with lime.
For more information
http://www.whfoods.com/genpage.php?tname=foo...
http://www.home-remedies-for-you.com/article...
http://www.syvum.com/cgi/online/serve.cgi/re...
Learn more: http://www.naturalnews.com/026372_cancer_papaya_protein.html#ixzz465wXKo6C
http://www.naturalnews.com/026372_cancer_papaya_enzymes.html
by: Barbara L. Minton
Tags: papaya, health news, Natural News
(NewsTarget) Sweet and succulent with a satiny consistency, papaya was referred to as the "fruit of the angels" by Christopher Columbus. Slice open a papaya and see hundreds of shiny black seeds that all need to get their start in life from the nutrition found in the fruit. This implies that fruit must be power-packed. Scientists have documented this common sense observation by finding that papaya promotes digestive health and intestinal cleansing, fights inflammation, and supports the immune system. It protects lung and joint health, revitalizes the body, and boosts energy levels. Papaya is a potent cancer fighter that is highly effective against hormone related cancers as well as other cancers. New research shows papaya can stop the growth of breast cancer cells, halt metastasis, and normalize the cell cycle.
Papaya was the only studied food found to halt breast cancer
Scientists studied 14 plant foods commonly consumed in Mexico to determine their ability to halt breast cancer cell growth. These included avocado, black sapote, fuava, mango, prickly pear cactus (nopal), pineapple, grapes, tomato, and papaya. They also evaluated beta-carotene, total plant phenolics, and gallic acid contents and antioxidant capacity. They found that only papaya had a significant effect on stopping breast cancer cell growth. (International Journal of Food Science and Nutrition, May)
Papaya is a store-house of cancer fighting lycopene
The intense orangey-pink color of papaya means it is chock full of cancer fighting carotenoids. Not only beta carotene, but lycopene is found in abundance. The construction of lycopene makes it highly reactive toward oxygen and free radicals. Scientists at the University of Illinois think this anti-oxidant activity contributes to its effectiveness as a cancer fighting agent. Epidemiological studies have indicated an inverse relationship between lycopene intake and prostate cancer risk. They showed that oral lycopene is highly bioavailable, accumulates in prostate tissue, and is localized in the nucleus of prostate epithelial cells.
In addition to antioxidant activity, other experiments have indicated that lycopene induces cancer cell death, anti-metastatic activity, and the up-regulation of protective enzymes. Phase I and II studies have established the safety of lycopene supplementation. (Cancer Letter, October 8, 2008)
Prostate cancer was the subject of a study in Australia that looked at 130 prostate cancer patients and 274 hospitalized controls. The scientists found that men who consumed the most lycopene-rich fruits and vegetables such as papaya were 82% less likely to have prostate cancer. In this study, green tea also exerted a powerful anti-cancer effect. When lycopene-rich foods were consumed with green tea, the combination was even more effective, an outcome the researchers credited to their synergy. (Asia Pacific Journal of Clinical Nutrition, 2007)
Isothiocyanates found in papaya restore the cell cycle to eliminate cancer
Organo-sulfur compounds called isothiocyanates are found in papaya. In animal experiments, isothiocyanates protected against cancers of the breast, lung, colon pancreas, and prostate, as well as leukemia, and they have the potential to prevent cancer in humans. Isothiocyanates have shown themselves capable of inhibiting both the formation and development of cancer cells through multiple pathways and mechanisms. (International Journal of Oncology), October, 2008)
Researchers in Japan clarified the mechanisms of action in a type of isothiocyanate found in papaya known as BITC, that underlies the relationship between cell cycle regulation and appropriate cell death. When cancerous cells die on schedule, they are no longer a problem. The researchers established that BITC exerted cancer cell killing effects that were greater in the proliferating cells than in the quiescent cells. Cancer cells that are proliferating are much more dangerous than cancer cells that are in a state of dormancy. (Forum of Nutrition, 2009)
Enzymes from papaya digest proteins including those that protect tumors
The fruit and other parts of the papaya tree, also known as the paw paw tree, contain papain and chymopapain, powerful proteolytic enzymes that facilitate chemical reactions in the body. They promote digestion by helping to break down proteins from food into amino acids that can be recombined to produce protein useable by humans. Proteolytic enzymes protect the body from inflammation and help heal burns. They do a good job of digesting unwanted scar tissue both on the skin and under its surface.
Research has shown that the physical and mental health of people is highly dependent on their ability to produce proteins they can use effectively. However, as people age, they produce less of the enzymes needed to effectively digest proteins from food and free needed amino acids. They are left with excessive amounts of undigested protein which can lead to overgrowth of unwanted bacteria in the intestinal tract, and a lack of available amino acids.
Eating papaya after a meal promotes digestion, and helps prevent bloating, gas production, and indigestion. It is quite helpful after antibiotic use to replenish friendly intestinal bacteria that were the casualties in the war against the unwanted bacteria. When the intestinal tract is well populated with friendly bacteria, the immune system is strengthened, and can better protect against flu and cancer.
Being a proteolytic enzyme, papain is able to destroy intestinal parasites, which are composed mostly of protein. To rid the body of intestinal parasites, half a cup of papaya juice can be alternated each hour for twelve consecutive hours with the same amount of cucumber or green bean juice.
Papaya contains fibrin, another useful compound not readily found in the plant kingdom. Fibrin reduces the risk of blood clots and improves the quality of blood cells, optimizing the ability of blood to flow through the circulatory system. Fibrin is also important in preventing stokes. Proteolytic enzymes containing fibrin are a good idea for long plane rides to minimize the potential of blood clots in the legs. People who sit at a desk all day might want to use proteolytic enzymes too.
Proteolytic enzymes are able to digest and destroy the defense shields of viruses, tumors, allergens, yeasts, and various forms of fungus. Once the shield is destroyed, tumors and invading organisms are extremely vulnerable and easily taken care of by the immune system.
Undigested proteins can penetrate the gut and wind up in the bloodstream where they are treated by the immune system as invaders. If too many undigested proteins are floating around, the immune system becomes overburdened and unable to attend to the other tasks it was meant to do. Proteolytic enzymes can digest these rogue proteins, freeing up the immune system.
Papaya offers luscious taste and super nutrition
Papayas are native to Central America. They were disbursed by Spanish and Portuguese explorers who journeyed to India, the Philippines and Africa. Today, most commercially available papaya is produced in the U.S., Mexico and Puerto Rico.
Papaya adds the sunlight of the tropics to summer drinks while flooding the body with high class antioxidants such as carotenes, vitamin C and flavonoids. It is rich in several B vitamins including folate and pantothenic acid. It contains ample amounts of potassium, and plenty of magnesium, the mineral most deficient in Americans. It is also a good source of fiber.
Try getting some of these nutrients with a Papaya-Banana Smoothie
Ingredients
1 cup of whatever kind of milk pleases you
1/4 cup Greek style yogurt
1 tsp pure vanilla extract
1/2 ripe papaya, peeled, seeded and chopped
1 banana, peeled and sliced
1 cup ice cubes
Directions
Combine all ingredients in a blender and blend until smooth. Pour into a large glass and garnish with lime.
For more information
http://www.whfoods.com/genpage.php?tname=foo...
http://www.home-remedies-for-you.com/article...
http://www.syvum.com/cgi/online/serve.cgi/re...
Learn more: http://www.naturalnews.com/026372_cancer_papaya_protein.html#ixzz465wXKo6C
🌸